Tufts Medicine posts operating loss of $31.8M with a -4.2% margin in Q1 2026, reflecting higher expenses despite revenue growth.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results